157 related articles for article (PubMed ID: 37481674)
61. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
[TBL] [Abstract][Full Text] [Related]
62. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
63. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Guo X; Sun Z; Jiang S; Jin X; Wang H
Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951
[TBL] [Abstract][Full Text] [Related]
64. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
[TBL] [Abstract][Full Text] [Related]
65. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Yamamura S; Saini S; Majid S; Hirata H; Ueno K; Chang I; Tanaka Y; Gupta A; Dahiya R
Carcinogenesis; 2012 Feb; 33(2):294-300. PubMed ID: 22159222
[TBL] [Abstract][Full Text] [Related]
67. Predictive values of Notch signalling in renal carcinoma.
Jędroszka D; Orzechowska M; Bednarek AK
Arch Med Sci; 2017 Oct; 13(6):1249-1254. PubMed ID: 29181054
[TBL] [Abstract][Full Text] [Related]
68. A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma.
Wu G; Xu Y; Zhang H; Ruan Z; Zhang P; Wang Z; Gao H; Che X; Xia Q; Chen F
Bioengineered; 2021 Dec; 12(1):7805-7819. PubMed ID: 34636718
[TBL] [Abstract][Full Text] [Related]
69. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
Ricketts CJ; Hill VK; Linehan WM
PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
[TBL] [Abstract][Full Text] [Related]
70. Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC).
Zhang Y; Lai H; Tang B
Dis Markers; 2021; 2021():4570235. PubMed ID: 34539936
[TBL] [Abstract][Full Text] [Related]
71. Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.
Mahajan S; Dammai V; Hsu T; Kraft AS
Carcinogenesis; 2008 Sep; 29(9):1734-41. PubMed ID: 18544564
[TBL] [Abstract][Full Text] [Related]
72. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
73. Identifying the role of transient receptor potential channels (TRPs) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses.
Ren J; Yuan Q; Liu J; Zhong L; Li H; Wu G; Chen F; Tang Q
BMC Med Genomics; 2022 Jul; 15(1):156. PubMed ID: 35831825
[TBL] [Abstract][Full Text] [Related]
74. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
75. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
76. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
77. Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma.
Kong G; Wang Y; Huang Y; Shi Z
Biomed Res Int; 2022; 2022():5563668. PubMed ID: 35127943
[TBL] [Abstract][Full Text] [Related]
78. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Song S; Chen N
Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
[TBL] [Abstract][Full Text] [Related]
79. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
[TBL] [Abstract][Full Text] [Related]
80. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]